MAPT and Alzheimer disease: Out of which, 61 subjects were diagnosed with AD and 55 diagnosed with MCI via different clinical assessments with low HMSE and ACEIII scores and on the basis of neuroimaging MRI, tau PET, FDG PET, and routine laboratory tests.